Sulbactam sodium/Ampicillin Sodium

舒巴坦钠/氨苄西林钠

Report date: 2024/01/18 15:18:14

Base Information

Drug NameSulbactam sodium/Ampicillin Sodium
Drug Alias Name氨苄西林钠/舒巴坦钠Sulbactam sodium and Ampicillin SodiumAmpicillin Sodium/Sulbactam sodiumUnasyn-SUnasyn
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryArgentina
Original Approved Date1983/01/01
Country/TerritoryUnited StatesArgentinaMainland China +[4] 
CombinationsYes Ampicillin SodiumSulbactam sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncZhongshan Lean & Leap Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CR01
Related LinksKEGG